UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 51 - 100 of 1748

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

AUA NY 2009 - Fluorescence cystoscopy for detection of initial and recurrent bladder cancer - Multimedia Presentation
Friday, 23 October 2009
SEWARD, AK, USA - Presented by Ihor S. Sawczuk, MD at the 107th Annual Meeting of the AUA - New York Section - August 19 - 26, 2009, Seward, Alaska, USA
Login to read more...

Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardization - Abstract
Friday, 23 October 2009
Università Cattolica S. Cuore, Policlinico A. Gemelli, Cattedra di Urologia, Rome, Italy.
read more

Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy - Abstract
Friday, 23 October 2009
Department of Urology, Faculty of Medicine, University of Ankara, Ankara, Turkey.
read more

Intermediate-risk group in patients with transitional cell carcinoma of the bladder: prediction of high-risk patients in this heterogeneous group - Abstract
Friday, 23 October 2009
Department of Urology, Yeditepe University Medical Faculty, Istanbul, Turkey.
read more

Intermittent self-catheterization and the risk of squamous cell cancer of the bladder: An emerging clinical entity? - Abstract
Friday, 23 October 2009
Department of Urology and Pathology, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
read more

Differential diagnosis of overactive bladder in men - Abstract
Friday, 23 October 2009
State University of New York Downstate Medical School, Brooklyn and Weill Medical College of Cornell University and Lenox Hill Hospital, New York, New York.
read more

Composite paraganglioma-ganglioneuroma of the urinary bladder: a rare neoplasm causing hemodynamic crisis at tumour resection - Abstract
Friday, 23 October 2009
Department of Pathology and Molecular Medicine, Department of Urology, Department of Anesthesiology, Kingston General Hospital and Queen’s University, Kingston, ON.
read more

Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach - Abstract
Thursday, 22 October 2009
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York.
read more

Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo - Abstract
Thursday, 22 October 2009
Department of Urology, Keio University School of Medicine, Tokyo, Japan.
read more

Practice patterns and recurrence after partial cystectomy for bladder cancer - Abstract
Thursday, 22 October 2009
Department of Surgery (Urology), McGill University, Montreal, QC, Canada.
read more

Focal amplifications are associated with high-grade and recurrences in stage Ta bladder carcinoma - Abstract
Wednesday, 21 October 2009
Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75185 Uppsala, Sweden.
read more

AUA NY 2009 - Detection of circulating tumor cells (CTC) - Multimedia Presentation
Tuesday, 20 October 2009
SEWARD, AK, USA - Presented by Nicholas Romas, MD at the 107th Annual Meeting of the AUA - New York Section - August 19 - 26, 2009, Seward, Alaska, USA
Login to read more...

Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors - Abstract
Tuesday, 20 October 2009
Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
read more

Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer - Abstract
Tuesday, 20 October 2009
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.
read more

Bacillus calmette-guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study - Abstract
Tuesday, 20 October 2009
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University Hospital, Umeå, Sweden.
read more

WCE 2009 - Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield - Session Highlights
Monday, 19 October 2009
MUNICH, GERMANY (UroToday.com) - The role of regional lymphadenectomy during uro-oncologic surgery is no more clear than it is for bladder cancer.
Login to read more...

WCE 2009 - Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost - Session Highlights
Monday, 19 October 2009
MUNICH, GERMANY (UroToday.com) - The adoption of Robot-Assisted Laparoscopic Radical Prostatectomy (RALP) into the uro-oncologists armamentarium has been relatively rapid, particularly in the United States.
Login to read more...

Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients - Abstract
Monday, 19 October 2009
Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
read more

Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guérin immunotherapy and mitomycin C intravesical therapy - Abstract
Monday, 19 October 2009
Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
read more

Evidence-based principles of bladder cancer and diet - Abstract
Monday, 19 October 2009
Division of Urology, Department of Surgery, University of California, San Diego Medical Center, San Diego, CA.
read more

Bladder cancer incidence and mortality rates compared to ecologic factors among states in America - Abstract
Friday, 16 October 2009
University of Alabama, Birmingham, AL, USA.
read more

Prognostic impact of HER2/neu protein in urothelial bladder cancer. Survival analysis of 80 cases and an overview of almost 20 years' research - Abstract
Friday, 16 October 2009
Department of Cytopathology, Aretaieion University Hospital, Athens, Greece.
read more

Urinary proteomic profiling for diagnostic bladder cancer biomarkers - Abstract
Friday, 16 October 2009
MD Anderson Cancer Center - Orlando, Cancer Research Institute, 6900 Lake Nona Boulevard, Orlando, FL 32827, USA.
read more

Cystoprostatectomy as a treatment of prostate cancer involving the bladder neck - Abstract
Thursday, 15 October 2009
Department of Urology, Akita University School of Medicine, Akita, Japan.
read more

Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male - Abstract
Thursday, 15 October 2009
Department of Urology, Brookdale University Hospital and Medical Center, Brooklyn, New York, USA.
read more

Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases - Abstract
Thursday, 15 October 2009
Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.
read more

Primary upper urinary tract tumors and subsequent location in the bladder - Abstract
Thursday, 15 October 2009
Service d'urologie, hôpital de la Pitié-Salpêtrière, Assistance-publique-Hôpitaux de Paris, groupe hospitalo-universitaire Est, faculté de médecine Pierre-et-Marie-Curie, université Paris-VI, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
read more

Anticancer drug improves survival and treatment for patients with advanced bladder cancer
Wednesday, 14 October 2009
CHICAGO, IL, USA (News Release) - October 13, 2009
read more

AUA MA 2009 - Hexaminolevulinate fluorescence cystoscopy improves detection and resection of papillary bladder cancer lesions and reduces early recurrences - Session Highlights
Wednesday, 14 October 2009
WILLIAMSBURG, VA, USA (UroToday.com) - Hexaminolevulinate (HAL) enhanced cystoscopy has the potential to identify bladder tumors not apparent on white light cystoscopy.
Login to read more...

Clinical states model for biomarkers in bladder cancer - Abstract
Wednesday, 14 October 2009
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
read more

Biomarkers in bladder cancer - Abstract
Wednesday, 14 October 2009
Department of Public Health Epidemiology and Biostatistics, School of Population Sciences, University of Birmingham, Birmingham, UK.
read more

Narrow-band imaging cystoscopy to evaluate the response to bacille Calmette-Guérin therapy: preliminary results - Abstract
Wednesday, 14 October 2009
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
read more

Intravesical therapy in non-muscle-invasive bladder cancer : Indications and practical considerations - Abstract
Wednesday, 14 October 2009
Klinik für Urologie und Kinderurologie, Universität, Prittwitzstrasse 43, 89075, Ulm, Deutschland.
read more

AUA MA 2009 - The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder - Session Highlights
Tuesday, 13 October 2009
WILLIAMSBURG, VA, USA (UroToday.com) - The immune-mediated killing effect of BCG is dependent on fibronectin mediated binding of BCG.
Login to read more...

AUA MA 2009 - Preoperative prediction of invasive upper-tract urothelial carcinoma stage using hydronephrosis, ureteroscopic biopsy grade, and urinary cytology - Session Highlights
Tuesday, 13 October 2009
WILLIAMSBURG, VA, USA (UroToday.com) - Clinical staging for upper tract urothelial carcinomas (UTUC) remains inadequate.
Login to read more...

AUA MA 2009 - Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the United States, 1973-2005 - Session Highlights
Tuesday, 13 October 2009
WILLIAMSBURG, VA, USA (UroToday.com) - Due to their relatively low incidence, upper tract urothelial carcinomas (UTUC) are difficult to study.
Login to read more...

AUA MA 2009 - Diagnostic accuracy of urinary cytology for upper-tract urothelial carcinoma (UTUC) - Session Highlights
Tuesday, 13 October 2009
WILLIAMSBURG, VA, USA (UroToday.com) - This study assessed the diagnostic accuracy of urine cytology alone in the management of upper tract urothelial carcinoma (UTUC).
Login to read more...

AUA MA 2009 - Is bladder cancer severity or long term outcomes after radical cystectomy affected by body mass index? - Session Highlights
Tuesday, 13 October 2009
WILLIAMSBURG, VA, USA (UroToday.com) - This study examined the effect of body mass index (BMI) on pathologic bladder cancer stage and survival at the time of radical cystectomy.
Login to read more...

Oral analgesia by non-steroidal anti-inflammatory drug zaltoprofen to manage cystoscopy-related pain: A prospective study - Abstract
Tuesday, 13 October 2009
Department of Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan.
read more

Bladder cancer associated protein: a potential prognostic biomarker in human bladder cancer - Abstract
Tuesday, 13 October 2009
Proteomics in Cancer, Danish Cancer Society, Copenhagen Ø DK-2100.
read more

Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis - Abstract
Tuesday, 13 October 2009
ABO Association, Center for the Study of Biological Markers of Malignancy, AULSS 12, Venice - Italy.
read more

AUA MA 2009 - Does the yield of random bladder biopsies justify their use in the assessment of patients following intravesical BCG therapy? - Session Highlights
Monday, 12 October 2009
WILLIAMSBURG, VA, USA (UroToday.com) - In this study, researchers from the University of Pennsylvania assessed the utility of targeted vs. random bladder biopsies following BCG therapy in patients with non muscle-invasive bladder cancer.
Login to read more...

Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion-A prospective cohort study with a systematic review of literature - Abstract
Monday, 12 October 2009
Urology, Aberdeen Royal Infirmary, UK.
read more

The effect of on-line position correction on the dose distribution in focal radiotherapy for bladder cancer - Abstract
Monday, 12 October 2009
The purpose of this study was to determine the dosimetric effect of on-line position correction for bladder tumor irradiation and to find methods to predict and handle this effect.
read more

MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL - Abstract
Friday, 09 October 2009
Department of Urology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
read more

Systemic absorption and pharmacokinetics of single-dose intravesical gemcitabine after transurethral resection of the bladder in non-muscle-invasive bladder cancer - Abstract
Friday, 09 October 2009
Urology Unit, Department of Specialty Surgery, E.O. Ospedali Galliera, Genoa, Italy.
read more

Extraperitoneal radical cystectomy with extraperitonealization of the ileal neobladder: a comparison to the transperitoneal technique - Abstract
Friday, 09 October 2009
Department of Urology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
read more

The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading - Abstract
Thursday, 08 October 2009
Department of Urology, Erasmus MC, Rotterdam, The Netherlands.
read more

Feasibility of T-cell-based adoptive immunotherapy in the first 12 patients with advanced urothelial urinary bladder cancer. Preliminary data on a new immunologic treatment based on the sentinel node concept - Abstract
Thursday, 08 October 2009
Department of Urology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
read more

Emerging apoptosis agonists for bladder cancer - Abstract
Thursday, 08 October 2009
University of Rostock, Department of Urology, E. Heydemann Street 6, 18057 Rostock, Germany.
read more

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts